Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial.

Autor: Peterson J; J Lewis Research, Salt Lake City, UT, USA., Drazan D; General Practice for Children and Adolescents, Jindrichuv Hradec, Czech Republic., Czajka H; College of Medical Sciences, University of Rzeszow, Rzeszow, Poland; Individual Specialist Medical Practice, Krakow, Poland., Maguire J; Pfizer Vaccine Research and Development, Pearl River, NY, USA. Electronic address: jason.maguire@pfizer.com., Pregaldien JL; Pfizer Vaccine Research and Development, Brussels, Belgium., Seppa I; Tampere University Vaccine Research Center, Tampere, Finland., Maansson R; Pfizer Vaccine Research and Development, Collegeville, PA, USA., O'Neill R; Pfizer Vaccine Research and Development, Pearl River, NY, USA., Balmer P; Pfizer Vaccine Medical Development and Scientific/Clinical Affairs, Collegeville, PA, USA., Jodar L; Pfizer Vaccine Medical Development and Scientific/Clinical Affairs, Collegeville, PA, USA., Jansen KU; Pfizer Vaccine Research and Development, Pearl River, NY, USA., Anderson AS; Pfizer Vaccine Research and Development, Pearl River, NY, USA., Perez JL; Pfizer Vaccine Research and Development, Collegeville, PA, USA., Beeslaar J; Pfizer Vaccine Research and Development, Hurley, UK.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Dec; Vol. 23 (12), pp. 1370-1382. Date of Electronic Publication: 2023 Aug 11.

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies.

Autor: Beeslaar J; Vaccine Clinical Research and Development, Pfizer Ltd UK, Hurley, UK. Johannes.Beeslaar@pfizer.com., Absalon J; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, NY, USA., Anderson AS; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Eiden JJ; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, NY, USA., Balmer P; Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Harris SL; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Jones TR; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., O'Neill RE; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Pregaldien JL; Vaccine Clinical Research and Development, Pfizer Inc, Brussels, Belgium., Radley D; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, NY, USA., Maansson R; Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USA., Ginis J; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA., Srivastava A; Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Perez JL; Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USA.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2020 Sep; Vol. 9 (3), pp. 641-656. Date of Electronic Publication: 2020 Jul 22.